Hedström M, Sjöberg K, Svensson J, Brosjö E, Dalén N
Karolinska Institutet, Department of Orthopaedics, Danderyd Hospital, Sweden.
Acta Orthop Scand. 2001 Jun;72(3):248-51. doi: 10.1080/00016470152846565.
We measured the levels of biochemical markers of bone formation and bone resorption in hip fracture patients preoperatively and after 6 and 12 months. Bone densitometry was done with quantitative computer tomography (QCT), dual-energy X-ray absorptiometry (DXA) and heel ultrasound. After 6 months, the biochemical markers of bone formation and bone resorption had increased. The levels remained high after 1 year and no change occurred between 6 and 12 months. We found no correlations between biochemical bone markers and bone density/stiffness on admission and change in bone mineral density (BMD) during the first postoperative year, despite the changes in bone markers and bone density. In our opinion, biochemical bone markers can not be used to predict bone loss in the individual patient after a hip fracture.
我们在髋部骨折患者术前以及术后6个月和12个月测量了骨形成和骨吸收的生化标志物水平。采用定量计算机断层扫描(QCT)、双能X线吸收法(DXA)和足跟超声进行骨密度测定。6个月后,骨形成和骨吸收的生化标志物有所增加。1年后这些水平仍保持较高,且在6至12个月之间没有变化。尽管骨标志物和骨密度有所改变,但我们发现入院时生化骨标志物与骨密度/硬度以及术后第一年骨矿物质密度(BMD)的变化之间没有相关性。我们认为,生化骨标志物不能用于预测髋部骨折后个体患者的骨质流失。